https://www.cnbctv18.com/market/emcure-pharma-ipo-listing-shares-debut-at-nearly-32-premium-over-ipo-price-19440897.htm
Last heard, shares of Emcure Pharmaceuticals were commanding a premium of ₹365 in the grey market, suggesting a listing pop of 36% for the investors.
Create an account or login to join the discussion